Articles Tagged With:
-
A Nutritional Approach to Prevent Alzheimer’s Disease
Moderate and high adherence to a blend of the Mediterranean and DASH diets helped to slow cognitive decline over 4.5 years in a cohort aged 58 years and older.
-
Diagnosis and Management of Influenza
Influenza hospitalizations and deaths occur mainly in high-risk groups such as the elderly, the chronically ill, and the very young.
-
Natriuretic Peptide Measurements May Help Diagnose Cardioembolic Stroke
The accurate diagnosis of cardioembolic stroke is extremely important since secondary prevention for this disorder, with antithrombotic therapy, is different than for other patients who might be treated with antiplatelet therapy. -
Cryptogenic Stroke and Atrial Fibrillation
In large prospective databases of ischemic stroke, cryptogenic stroke occurs in as many as 30% of all ischemic stroke patients. -
Cognitive Function in Creutzfeldt-Jakob Disease
The cognitive dysfunction profile in CJD impairs executive function, expressive speech, and parietal function more than memory functions.
-
Non-Ischemic Forearm Exercise Testing for McArdle’s Disease
Traditionally, the ischemic forearm exercise test has been used to help in the diagnosis of glycogen storage diseases of muscle, but this test is fraught with dangerous complications. A non-ischemic forearm test has been proven to be highly sensitive and specific, with minimal side effects, and should replace the traditional test.
-
Repetitive Transcranial Magnetic Stimulation for Treatment of Parkinson’s Disease
In several randomized, sham-controlled trials, repetitive transcranial magnetic stimulation was shown to be effective in reducing the motor manifestations of Parkinson’s disease, with minimal side effects.
-
Linking Traumatic Brain Injury and Parkinson’s Disease: The Evidence Builds
A retrospective study based on an administrative database compared more than 50,000 admissions with traumatic brain injury (TBI) with more than 100,000 admissions for other traumatic injury, and found that TBI in individuals older than 55 years of age led to a 44% increased risk of developing Parkinson’s disease in the ensuing 5-7 years.
-
REM Behavior Disorder — A Unique Window into the Mysteries of Neurodegenerative Disease
REM behavior disorder may precede α-synucleinopathies by decades and may be a biomarker of future disease.
-
Hospital Consult - May 2015